Cargando…

Aspirin for Primary Prevention: A Challenging Decision

Detalles Bibliográficos
Autor principal:	Pignone, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310420/ https://www.ncbi.nlm.nih.gov/pubmed/25146710 http://dx.doi.org/10.1161/JAHA.114.001254

Ejemplares similares

Aspirin for primary prevention in the elderly
por: Saad, Marwan, et al.
Publicado: (2019)

Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)

Aspirin—Another Type of Headache it Prevents
por: Loch Macdonald, R.
Publicado: (2013)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

Aspirin in primary prevention: who is the target?
por: Gatto, Laura, et al.
Publicado: (2019)

Aspirin for primary prevention: Is this the end of the road?
por: Singal, Aayush Kumar, et al.
Publicado: (2019)

Aspirin in primary prevention: USPSTF recommendations
por: Aalbers, J
Publicado: (2010)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Challenging the “Divinity” of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease
por: Spartalis, Michael, et al.
Publicado: (2023)

Aspirin overutilization for the primary prevention of cardiovascular disease
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Aspirin for the primary prevention of cardiovascular disease in the elderly
por: O’Sullivan, Jack W
Publicado: (2019)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
por: Coccheri, Sergio
Publicado: (2017)

Aspirin in primary prevention of cardiovascular disease in diabetes
por: Papazafiropoulou, Athanasia K., et al.
Publicado: (2021)

Can pre-race aspirin prevent sudden cardiac death during marathons?
por: Siegel, Arthur J, et al.
Publicado: (2017)

Aspirin in the era of immunotherapy
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Aspirin: the miracle drug?
por: Thota, Prashanthi N.
Publicado: (2018)

Should I take aspirin? A qualitative study on the implementation of a decision aid on taking aspirin for bowel cancer prevention
por: Onwuka, Shakira, et al.
Publicado: (2023)

Use of Aspirin and Statin as primary prevention for cardiovascular diseases
por: Alkhail, Bahaa Aba, et al.
Publicado: (2016)

POTENTIAL IMPLICATIONS OF ASPREE ON ASPIRIN PRIMARY PREVENTION GUIDELINES
por: Murray, Anne M
Publicado: (2019)

Primary prevention of myocardial infarction: aspirin is not as useful as it seems
por: Luan, Yi, et al.
Publicado: (2020)

Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Aspirin for the primary prevention of skin cancer: A meta-analysis
por: ZHU, YUN, et al.
Publicado: (2015)

The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial
por: Sheridan, Stacey L, et al.
Publicado: (2006)

Aspirin as Primary Prevention of Acute Coronary Heart Disease Events
por: Glasser, Stephen P., et al.
Publicado: (2014)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort
por: Caldeira, D., et al.
Publicado: (2023)

Aspirin for Prevention of Preeclampsia
por: Atallah, A., et al.
Publicado: (2017)

Injury prevention decision science
por: McClure, Roderick J
Publicado: (2021)

Initial Steps to Prevent Nonsteroidal Anti-Inflammatory Drug- or Aspirin-Induced Enteropathy: Long-Term Outcome Data
por: Lee, In Seok, et al.
Publicado: (2015)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

Aspirin therapy for cancer: it is never too late
por: Jankowski, J A Z, et al.
Publicado: (2011)

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
por: Schmaier, Alec A., et al.
Publicado: (2018)

Low-dose Btk inhibitors: an ‘aspirin’ of tomorrow?
por: Payrastre, Bernard, et al.
Publicado: (2021)

Further evidence for the use of aspirin in COVID-19
por: Tantry, Udaya S., et al.
Publicado: (2022)

Does an ‘aspirin-a-day’ keep the doctor away?
por: Berkel, H J
Publicado: (1999)

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
por: Pignone, Michael, et al.
Publicado: (2010)

Which people should take aspirin for primary prevention of cardiovascular disease?
por: Lozano, Roberto, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_amkd1uecnd97ukasqsc9rv6ern